# Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes

> **NCT00435981** · PHASE2 · COMPLETED · sponsor: **Diamyd Therapeutics AB** · enrollment: 70 (—)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** rhGAD65 formulated in Alhydrogel® (Diamyd®)

## Key facts

- **NCT ID:** NCT00435981
- **Lead sponsor:** Diamyd Therapeutics AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-10
- **Final completion:** 2007-12
- **Target enrollment:** 70 (—)
- **Last updated:** 2008-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00435981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00435981, "Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00435981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*